Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tissue factor in infection and severe inflammation.

Marcel Levi1, Tom van der Poll, Hugo ten Cate

  • 1Department of Internal Medicine, Academic Medical Center, University of Amsterdam, The Netherlands. m.m.levi@amc.uva.nl

Seminars in Thrombosis and Hemostasis
|February 16, 2006
PubMed
Summary

Inflammation and coagulation are key in vascular disease. Tissue factor (TF) links these systems, and inhibiting TF may offer therapeutic benefits for related conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Current opinion: the OCEANIC trial journey: from failure to breakthrough?

European heart journal. Cardiovascular pharmacotherapy·2026
Same author

Antidotes for Anticoagulation Reversal.

The New England journal of medicine·2026
Same author

Intrinsic activated thrombin generation for treatment efficacy and monitoring of octocog alfa and emicizumab in severe hemophilia A.

Research and practice in thrombosis and haemostasis·2026
Same author

Inhibition of inflammation reduces hypofibrinolysis in severe COVID-19: A nested case-control study within the MaastrICCht cohort.

Thrombosis research·2026
Same author

Thrombin generation and the pharmacodynamics of parenteral anticoagulants.

Pharmacological reviews·2026
Same author

Andexanet alfa for the reversal of anticoagulation: Dutch practice data.

Research and practice in thrombosis and haemostasis·2026

Area of Science:

  • Cardiovascular Science
  • Immunology
  • Hematology

Background:

  • Inflammation and coagulation are critical in vascular disease pathogenesis.
  • These systems exhibit significant cross-talk, influencing each other's activity.

Purpose of the Study:

  • To explore the role of tissue factor (TF) at the intersection of inflammation and coagulation.
  • To review the potential therapeutic implications of TF inhibition in vascular diseases.

Main Methods:

  • Literature review of experimental evidence on TF's role in inflammation and coagulation.
  • Analysis of TF's function as a coagulation initiator and inflammation modulator.

Main Results:

  • Proinflammatory cytokines induce TF expression, initiating thrombin generation.

Related Experiment Videos

  • TF binding to cellular receptors influences inflammatory mediator release.
  • Experimental data suggests TF inhibition may benefit diseases involving both inflammation and coagulation.

    • Conclusions:

    • Tissue factor is a central mediator linking inflammation and coagulation in vascular disease.
    • Targeting TF presents a promising therapeutic strategy for complex vascular pathologies.